A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with< 30% blasts
dc.contributor.author | Garcia-Manero, G. | |
dc.contributor.author | Sekeres, M. A. | |
dc.contributor.author | Egyed, Miklós | |
dc.contributor.author | Breccia, M. | |
dc.contributor.author | Graux, C. | |
dc.contributor.author | Cavenagh, J. D. | |
dc.contributor.author | Salman, H. | |
dc.contributor.author | Illés, Árpád | |
dc.contributor.author | Fenaux, Pierre | |
dc.contributor.author | DeAngelo, D. J. | |
dc.contributor.author | Stauder, R. | |
dc.contributor.author | Yee, K. | |
dc.contributor.author | Zhu, N. | |
dc.contributor.author | Lee, J. H. | |
dc.contributor.author | Valcarcel, D. | |
dc.contributor.author | MacWhannell, A. | |
dc.contributor.author | Borbényi, Zita | |
dc.contributor.author | Gazi, L. | |
dc.contributor.author | Acharyya, S. | |
dc.contributor.author | Ide, S. | |
dc.contributor.author | Marker, M. | |
dc.contributor.author | Ottmann, O. G. | |
dc.date.accessioned | 2017-08-03T09:03:33Z | |
dc.date.available | 2017-08-03T09:03:33Z | |
dc.date.issued | 2017 | |
dc.date.oa | 2018-03-29 | |
dc.date.pasync | 2021-03-09T01:30:20Z | |
dc.date.updated | 2021-03-09T01:30:20Z | |
dc.description.corrector | KA | |
dc.identifier.citation | Leukemia. - 31 : 12 (2017), p. 2799-2806. -Leukemia. - 0887-6924 | |
dc.identifier.doi | http://dx.doi.org/10.1038/leu.2017.159 | |
dc.identifier.issn | 0887-6924 | |
dc.identifier.opac | http://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM070026 | |
dc.identifier.original | https://www.nature.com/articles/leu2017159 | |
dc.identifier.uri | http://hdl.handle.net/2437/242857 | |
dc.language | eng | |
dc.rights.access | open access pre-print és post-print | |
dc.rights.embargo | 6 hónap | |
dc.rights.owner | Nature Publishing Group | |
dc.subject.mab | Orvostudományok | |
dc.subject.mab | Klinikai orvostudományok | |
dc.title | A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with< 30% blasts | |
dc.type | folyóiratcikk | |
dc.type | idegen nyelvű folyóiratközlemény külföldi lapban |